The rise in chronic illnesses and the development and use of biologics and biosimilars is fueling the demand for advanced injectable systems, which is propelling the global injectable drug delivery market size.
Innovations in delivery technologies, such as prefilled syringes, auto-injectors, pen injectors, and needle-free systems, enhance patient compliance and convenience.
Major players in the market are significantly investing in research & development activities and signing strategic partnerships to launch cutting-edge and efficient delivery systems. They are foraying into emerging countries for sustained expansion.
Furthermore, regulatory approvals for innovative injectable medicines is driving the injectable drug delivery industry growth. Surge in product approvals by regulatory bodies is expected to propel the injectable drug delivery market share of North America during the forecast period
Injectable drug delivery refers to the method of administering medication directly into the body through a needle or similar device. This delivery system allows for the rapid and controlled release of drugs into the bloodstream, tissues, or specific organs.
Many pharmaceuticals, such as insulin, biologics, vaccines, and other therapeutic agents, are administered via injectable drug administration, which offers the benefits of accurate dosing, fast therapeutic effects, and suitability for treatments that are poorly absorbed or broken down in the digestive tract.
However, the risk of needle-stick injuries and infections are expected to be market limitations. Healthcare professionals are more vulnerable to these dangers due to their frequent contact with needles.
Serious health issues, such as the spread of blood-borne infections, including HIV, hepatitis B, and hepatitis C, can arise from such injuries. Thus, healthcare facilities and practitioners may be hesitant to employ injectable devices widely due to the fear and liability that come with these hazards.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Increase in prevalence of disorders and diseases such as malaria, diabetes, cancer, HIV, and autoimmune diseases is driving the need for injectable medicines that can provide precise amounts straight into the bloodstream for quick and efficient therapy. This surge in demand necessitates the development and availability of advanced injectable devices, thereby fueling market progress.
The chronic nature of many of these diseases often requires long-term treatment, further boosting the need for convenient and user-friendly injectable solutions that improve patient compliance and outcomes and boosting the injectable drug delivery market revenue.
According to data published by American Diabetes Association in November 2023, 38.4 million Americans, or 11.6% of the population, had diabetes in 2021. Around 2 million Americans had type 1 diabetes, including about 304,000 children and adolescents, in 2021.
The percentage of Americans aged 65 and older remains high, at 29.2%, or 16.5 million seniors (diagnosed and undiagnosed). These statistics highlight the major role of insulin administration to this patient pool.
The field of injectable drug delivery is undergoing a revolution, with advancements that not only improve patient experience but also fuels market growth.
In January 2023, scientists at the University of Toronto used artificial intelligence to fast-track drug formulation development, significantly reducing the time and cost associated with bringing new injectable therapies to market.
University of Toronto scientists successfully tested the use of artificial intelligence to guide the design of long-acting injectable drug formulations. Their multidisciplinary research shows that machine-learning algorithms can be used to predict experimental drug release from long-acting injectables (LAI) and can help guide the design of new LAIs.
These advancements not only streamline the development process but also ensure higher precision in drug delivery, addressing the needs of both patients and healthcare providers and thus boosting the injectable drug delivery market development.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the injectable drug delivery market analysis, North America dominated the landscape in 2023 and the trend is expected to remain unchanged during the forecast period. Advanced pharmaceutical research, high healthcare spending, and a significant prevalence of chronic diseases are driving market dynamics in the region.
Additionally, the increase in product approvals by regulatory bodies is expected to drive market statistics in the region. In April 2022, Nevakar Injectables Inc. a wholly owned subsidiary of Nevakar, Inc., a biopharmaceutical company, announced that the U.S. Food and Drug Administration had approved its ready-to-use Ephedrine Sulfate Injection in a prefilled syringe.
Ephedrine is a widely used injectable vasopressor agent indicated for the treatment of clinically important hypotension occurring during surgery.
According to the injectable drug delivery market report, key players are involved in new product launch to reach out to a larger customer base. For instance, in April 2024, Amneal Pharmaceuticals, Inc., a fully integrated global essential medicines company, announced the launch of PEMRYDI RTU, the first and only ready-to-use presentation of pemetrexed for injection.
This product does not require reconstitution, dilution, or refrigeration, which is different than other versions of pemetrexed for injection. Companies operating in the market are also engaging in inorganic modes of expansion on this count.
In June 2024, Aptar Digital Health, a global leader in digital health solutions, connected devices, and disease management, and SHL Medical, a world-leading solutions provider of advanced drug delivery systems such as autoinjectors, pen injectors, and innovative specialty delivery systems, announced a strategic partnership.
The partnership is likely to extend SHL Medical’s connected device technologies by integrating Aptar Digital Health’s SaMD platform to provide comprehensive solutions to help patients on injectable therapies manage their disease.
Becton, Dickinson, and Company (BD), Pfizer, Inc., Eli Lilly and Company, Baxter International, Inc., Terumo Corporation, B. Braun Melsungen AG, Ypsomed AG, Gerresheimer AG, SCHOTT Pharma, and Hi-Tech Syringes are the prominent injectable drug delivery market players.
Key players have been profiled in the injectable drug delivery market research report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 689.5 Bn |
| Market Forecast (Value) in 2034 | US$ 1.9 Trn |
| Growth Rate (CAGR) | 9.8% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn/Trn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 689.5 Bn in 2023
It is projected to grow at a CAGR of 9.8% from 2024 to 2034
Increase in product approvals by regulatory bodies
By product type, the formulations segment accounted for the largest share in 2023
North America was the dominant region in 2023
Becton, Dickinson, and Company (BD), Pfizer, Inc., Eli Lilly and Company, Baxter International, Inc., Terumo Corporation, B. Braun Melsungen AG, Ypsomed AG, Gerresheimer AG, SCHOTT Pharma, and Hi-Tech Syringes
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Injectable Drug Delivery Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Injectable Drug Delivery Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. PEST Analysis
5.2. Product Launches and Approvals
5.3. Regulatory Landscape for Injectable Drug Delivery in Key Regions / Countries
5.4. FDA Drug Approval Process
5.5. Key Industry Events (Acquisition, Partnerships, And Collaborations)
6. Global Injectable Drug Delivery Market Analysis and Forecasts, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product Type, 2020-2034
6.3.1. Devices
6.3.1.1. Conventional Injection Devices
6.3.1.2. Self Injection Devices
6.3.1.3. Others
6.3.2. Formulations
6.3.2.1. Conventional Drug Delivery Formulations
6.3.2.2. Novel Drug Delivery Formulations
6.3.2.3. Long Lasting Injection Formulations
6.4. Market Attractiveness By Product Type
7. Global Injectable Drug Delivery Market Analysis and Forecasts, By Therapeutic Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Therapeutic Application, 2020-2034
7.3.1. Autoimmune Disease
7.3.2. Hormone Disease
7.3.3. Orphan Disease
7.3.4. Cancer
7.3.5. Cardiovascular Disease
7.3.6. Infectious Disease
7.3.7. Others
7.4. Market Attractiveness By Therapeutic Application
8. Global Injectable Drug Delivery Market Analysis and Forecasts, By Usage Pattern
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Usage Pattern, 2020-2034
8.3.1. Curative Care
8.3.2. Immunization
8.3.3. Others
8.4. Market Attractiveness By Usage Pattern
9. Global Injectable Drug Delivery Market Analysis and Forecasts, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user, 2020-2034
9.3.1. Hospitals and Clinics
9.3.2. Ambulatory Surgical Centers
9.3.3. Home Care Settings
9.3.4. Others
9.4. Market Attractiveness By End-user
10. Global Injectable Drug Delivery Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Injectable Drug Delivery Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product Type, 2020-2034
11.2.1. Devices
11.2.1.1. Conventional Injection Devices
11.2.1.2. Self Injection Devices
11.2.1.3. Others
11.2.2. Formulations
11.2.2.1. Conventional Drug Delivery Formulations
11.2.2.2. Novel Drug Delivery Formulations
11.2.2.3. Long Lasting Injection Formulations
11.3. Market Value Forecast By Therapeutic Application, 2020-2034
11.3.1. Autoimmune Disease
11.3.2. Hormone Disease
11.3.3. Orphan Disease
11.3.4. Cancer
11.3.5. Cardiovascular Disease
11.3.6. Infectious Disease
11.3.7. Others
11.4. Market Value Forecast By Usage Pattern, 2020-2034
11.4.1. Curative Care
11.4.2. Immunization
11.4.3. Others
11.5. Market Value Forecast By End-user, 2020-2034
11.5.1. Hospitals and Clinics
11.5.2. Ambulatory Surgical Centers
11.5.3. Home Care Settings
11.5.4. Others
11.6. Market Value Forecast By Country, 2020-2034
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Therapeutic Application
11.7.3. By Usage Pattern
11.7.4. By End-user
11.7.5. By Country
12. Europe Injectable Drug Delivery Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product Type, 2020-2034
12.2.1. Devices
12.2.1.1. Conventional Injection Devices
12.2.1.2. Self Injection Devices
12.2.1.3. Others
12.2.2. Formulations
12.2.2.1. Conventional Drug Delivery Formulations
12.2.2.2. Novel Drug Delivery Formulations
12.2.2.3. Long Lasting Injection Formulations
12.3. Market Value Forecast By Therapeutic Application, 2020-2034
12.3.1. Autoimmune Disease
12.3.2. Hormone Disease
12.3.3. Orphan Disease
12.3.4. Cancer
12.3.5. Cardiovascular Disease
12.3.6. Infectious Disease
12.3.7. Others
12.4. Market Value Forecast By Usage Pattern, 2020-2034
12.4.1. Curative Care
12.4.2. Immunization
12.4.3. Others
12.5. Market Value Forecast By End-user, 2020-2034
12.5.1. Hospitals and Clinics
12.5.2. Ambulatory Surgical Centers
12.5.3. Home Care Settings
12.5.4. Others
12.6. Market Value Forecast By Country, 2020-2034
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Therapeutic Application
12.7.3. By Usage Pattern
12.7.4. By End-user
12.7.5. By Country
13. Asia Pacific Injectable Drug Delivery Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product Type, 2020-2034
13.2.1. Devices
13.2.1.1. Conventional Injection Devices
13.2.1.2. Self Injection Devices
13.2.1.3. Others
13.2.2. Formulations
13.2.2.1. Conventional Drug Delivery Formulations
13.2.2.2. Novel Drug Delivery Formulations
13.2.2.3. Long Lasting Injection Formulations
13.3. Market Value Forecast By Therapeutic Application, 2020-2034
13.3.1. Autoimmune Disease
13.3.2. Hormone Disease
13.3.3. Orphan Disease
13.3.4. Cancer
13.3.5. Cardiovascular Disease
13.3.6. Infectious Disease
13.3.7. Others
13.4. Market Value Forecast By Usage Pattern, 2020-2034
13.4.1. Curative Care
13.4.2. Immunization
13.4.3. Others
13.5. Market Value Forecast By End-user, 2020-2034
13.5.1. Hospitals and Clinics
13.5.2. Ambulatory Surgical Centers
13.5.3. Home Care Settings
13.5.4. Others
13.6. Market Value Forecast By Country, 2020-2034
13.6.1. China
13.6.2. India
13.6.3. Japan
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Therapeutic Application
13.7.3. By Usage Pattern
13.7.4. By End-user
13.7.5. By Country
14. Latin America Injectable Drug Delivery Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product Type, 2020-2034
14.2.1. Devices
14.2.1.1. Conventional Injection Devices
14.2.1.2. Self Injection Devices
14.2.1.3. Others
14.2.2. Formulations
14.2.2.1. Conventional Drug Delivery Formulations
14.2.2.2. Novel Drug Delivery Formulations
14.2.2.3. Long Lasting Injection Formulations
14.3. Market Value Forecast By Therapeutic Application, 2020-2034
14.3.1. Autoimmune Disease
14.3.2. Hormone Disease
14.3.3. Orphan Disease
14.3.4. Cancer
14.3.5. Cardiovascular Disease
14.3.6. Infectious Disease
14.3.7. Others
14.4. Market Value Forecast By Usage Pattern, 2020-2034
14.4.1. Curative Care
14.4.2. Immunization
14.4.3. Others
14.5. Market Value Forecast By End-user, 2020-2034
14.5.1. Hospitals and Clinics
14.5.2. Ambulatory Surgical Centers
14.5.3. Home Care Settings
14.5.4. Others
14.6. Market Value Forecast By Country, 2020-2034
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Therapeutic Application
14.7.3. By Usage Pattern
14.7.4. By End-user
14.7.5. By Country
15. Middle East & Africa Injectable Drug Delivery Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product Type, 2020-2034
15.2.1. Devices
15.2.1.1. Conventional Injection Devices
15.2.1.2. Self Injection Devices
15.2.1.3. Others
15.2.2. Formulations
15.2.2.1. Conventional Drug Delivery Formulations
15.2.2.2. Novel Drug Delivery Formulations
15.2.2.3. Long Lasting Injection Formulations
15.3. Market Value Forecast By Therapeutic Application, 2020-2034
15.3.1. Autoimmune Disease
15.3.2. Hormone Disease
15.3.3. Orphan Disease
15.3.4. Cancer
15.3.5. Cardiovascular Disease
15.3.6. Infectious Disease
15.3.7. Others
15.4. Market Value Forecast By Usage Pattern, 2020-2034
15.4.1. Curative Care
15.4.2. Immunization
15.4.3. Others
15.5. Market Value Forecast By End-user, 2020-2034
15.5.1. Hospitals and Clinics
15.5.2. Ambulatory Surgical Centers
15.5.3. Home Care Settings
15.5.4. Others
15.6. Market Value Forecast By Country, 2020-2034
15.6.1. GCC
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Therapeutic Application
15.7.3. By Usage Pattern
15.7.4. By End-user
15.7.5. By Country
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2021)
16.3. Market Footprint Analysis
16.3.1. By Region
16.3.2. By Product Type
16.4. Competitive Business Strategies
16.5. Company Profiles
16.5.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.5.2. Market Share Analysis, by Company (2023)
16.5.3. Company Profiles
16.5.3.1. Becton, Dickinson, and Company (BD)
16.5.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.1.2. Product Portfolio
16.5.3.1.3. Financial Overview
16.5.3.1.4. SWOT Analysis
16.5.3.1.5. Strategic Overview
16.5.3.2. Pfizer, Inc.
16.5.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.2.2. Product Portfolio
16.5.3.2.3. Financial Overview
16.5.3.2.4. SWOT Analysis
16.5.3.2.5. Strategic Overview
16.5.3.3. Eli Lilly and Company
16.5.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.3.2. Product Portfolio
16.5.3.3.3. Financial Overview
16.5.3.3.4. SWOT Analysis
16.5.3.3.5. Strategic Overview
16.5.3.4. Baxter International, Inc.
16.5.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.4.2. Product Portfolio
16.5.3.4.3. Financial Overview
16.5.3.4.4. SWOT Analysis
16.5.3.4.5. Strategic Overview
16.5.3.5. Terumo Corporation
16.5.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.5.2. Product Portfolio
16.5.3.5.3. Financial Overview
16.5.3.5.4. SWOT Analysis
16.5.3.5.5. Strategic Overview
16.5.3.6. B. Braun Melsungen AG
16.5.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.6.2. Product Portfolio
16.5.3.6.3. Financial Overview
16.5.3.6.4. SWOT Analysis
16.5.3.6.5. Strategic Overview
16.5.3.7. Ypsomed AG
16.5.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.7.2. Product Portfolio
16.5.3.7.3. Financial Overview
16.5.3.7.4. SWOT Analysis
16.5.3.7.5. Strategic Overview
16.5.3.8. Gerresheimer AG
16.5.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.8.2. Product Portfolio
16.5.3.8.3. Financial Overview
16.5.3.8.4. SWOT Analysis
16.5.3.8.5. Strategic Overview
16.5.3.9. SCHOTT Pharma
16.5.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.9.2. Product Portfolio
16.5.3.9.3. Financial Overview
16.5.3.9.4. SWOT Analysis
16.5.3.9.5. Strategic Overview
16.5.3.10. Hi-Tech Syringes
16.5.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.5.3.10.2. Product Portfolio
16.5.3.10.3. Financial Overview
16.5.3.10.4. SWOT Analysis
16.5.3.10.5. Strategic Overview
List of Tables
Table 01: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 02: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
Table 03: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
Table 04: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
Table 05: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
Table 06: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 07: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 08: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 09: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 10: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
Table 11: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
Table 12: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
Table 13: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
Table 14: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 15: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 16: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 17: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
Table 18: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
Table 19: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
Table 20: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
Table 21: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 22: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 23: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 24: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
Table 25: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
Table 26: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
Table 27: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
Table 28: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 29: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 30: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 31: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
Table 32: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
Table 33: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
Table 34: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
Table 35: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 36: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 37: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
Table 38: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
Table 39: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
Table 40: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
Table 41: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
Table 42: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Injectable Drug Delivery Market Value (US$ Bn) Forecast, 2020-2034
Figure 02: Global Injectable Drug Delivery Market Value Share, by Product Type, 2023
Figure 03: Global Injectable Drug Delivery Market Value Share, by Therapeutic Application, 2023
Figure 04: Global Injectable Drug Delivery Market Value Share, by Usage Pattern, 2023
Figure 05: Global Injectable Drug Delivery Market Value Share, by End-user, 2023
Figure 06: Global Injectable Drug Delivery Market Value Share, by Region, 2023
Figure 07: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by Product Type, 2023 and 2034
Figure 08: Global Injectable Drug Delivery Market Share Analysis, by Product Type, 2023
Figure 09: Global Injectable Drug Delivery Market Share Analysis, by Product Type, 2034
Figure 10: Global Injectable Drug Delivery Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 11: Global Injectable Drug Delivery Market Value (US$ Bn), by Devices Product Type, 2020-2034
Figure 12: Global Injectable Drug Delivery Market Value Share Analysis, by Devices Product Type, 2023 and 2034
Figure 13: Global Injectable Drug Delivery Market Value (US$ Bn), by Formulations Product Type, 2020-2034
Figure 14: Global Injectable Drug Delivery Market Value Share Analysis, by Formulations Product Type, 2023 and 2034
Figure 15: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by Therapeutic Application, 2023 and 2034
Figure 16: Global Injectable Drug Delivery Market Share Analysis, by Therapeutic Application, 2023
Figure 17: Global Injectable Drug Delivery Market Share Analysis, by Therapeutic Application, 2034
Figure 18: Global Injectable Drug Delivery Market Attractiveness Analysis, by Therapeutic Application, 2024-2034
Figure 19: Global Injectable Drug Delivery Market Value (US$ Bn), by Autoimmune Disease, 2020-2034
Figure 20: Global Injectable Drug Delivery Market Value Share Analysis, by Autoimmune Disease, 2023 and 2034
Figure 21: Global Injectable Drug Delivery Market Value (US$ Bn), by Hormone Disease, 2020-2034
Figure 22: Global Injectable Drug Delivery Market Value (US$ Bn), by Hormone Disease, 2020-2034
Figure 23: Global Injectable Drug Delivery Market Value (US$ Bn), by Orphan Disease, 2020-2034
Figure 24: Global Injectable Drug Delivery Market Value Share Analysis, by Orphan Disease, 2023 and 2034
Figure 25: Global Injectable Drug Delivery Market Value (US$ Bn), by Cancer, 2020-2034
Figure 26: Global Injectable Drug Delivery Market Value Share Analysis, by Cancer, 2023 and 2034
Figure 27: Global Injectable Drug Delivery Market Value (US$ Bn), by Cardiovascular Disease, 2020-2034
Figure 28: Global Injectable Drug Delivery Market Value Share Analysis, by Cardiovascular Disease, 2023 and 2034
Figure 29: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by Infectious Disease, 2023 and 2034
Figure 30: Global Injectable Drug Delivery Market Value Share Analysis, by Infectious Disease, 2023 and 2034
Figure 31: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by Others, 2023 and 2034
Figure 32: Global Injectable Drug Delivery Market Value Share Analysis, by Others, 2023 and 2034
Figure 33: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by Usage Pattern, 2023 and 2034
Figure 34: Global Injectable Drug Delivery Market Share Analysis, by Usage Pattern, 2023
Figure 35: Global Injectable Drug Delivery Market Share Analysis, by Usage Pattern, 2034
Figure 36: Global Injectable Drug Delivery Market Attractiveness Analysis, by Usage Pattern, 2024-2034
Figure 37: Global Injectable Drug Delivery Market Value (US$ Bn), by Curative Care, 2020-2034
Figure 38: Global Injectable Drug Delivery Market Value Share Analysis, by Curative Care, 2023 and 2034
Figure 39: Global Injectable Drug Delivery Market Value (US$ Bn), by Immunization, 2020-2034
Figure 40: Global Injectable Drug Delivery Market Value Share Analysis, by Immunization, 2023 and 2034
Figure 41: Global Injectable Drug Delivery Market Value (US$ Bn), by Others, 2020-2034
Figure 42: Global Injectable Drug Delivery Market Value Share Analysis, by Others, 2023 and 2034
Figure 43: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
Figure 44: Global Injectable Drug Delivery Market Share Analysis, by End-user, 2023
Figure 45: Global Injectable Drug Delivery Market Share Analysis, by End-user, 2034
Figure 46: Global Injectable Drug Delivery Market Attractiveness Analysis, by End-user, 2024-2034
Figure 47: Global Injectable Drug Delivery Market Value (US$ Bn), by Hospitals and Clinics, 2020-2034
Figure 48: Global Injectable Drug Delivery Market Value Share Analysis, by Hospitals and Clinics, 2023 and 2034
Figure 49: Global Injectable Drug Delivery Market Value (US$ Bn), by Ambulatory Surgical Centers, 2020-2034
Figure 50: Global Injectable Drug Delivery Market Value Share Analysis, by Ambulatory Surgical Centers, 2023 and 2034
Figure 51: Global Injectable Drug Delivery Market Value (US$ Bn), by Home Care Settings, 2020-2034
Figure 52: Global Injectable Drug Delivery Market Value Share Analysis, by Home Care Settings, 2023 and 2034
Figure 53: Global Injectable Drug Delivery Market Value (US$ Bn), by Others, 2020-2034
Figure 54: Global Injectable Drug Delivery Market Value Share Analysis, by Others, 2023 and 2034
Figure 55: Global Injectable Drug Delivery Market Value Share Analysis, by Region, 2023 and 2034
Figure 56: Global Injectable Drug Delivery Market Share Analysis, by Region, 2023
Figure 57: Global Injectable Drug Delivery Market Share Analysis, by Region, 2034
Figure 58: Global Injectable Drug Delivery Market Attractiveness Analysis, by Region, 2023-2034
Figure 59: North America Injectable Drug Delivery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 60: North America Injectable Drug Delivery Market Attractiveness Analysis, by Country, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Injectable Drug Delivery Market
